1. Home
  2. CSBR vs MAXN Comparison

CSBR vs MAXN Comparison

Compare CSBR & MAXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CSBR
  • MAXN
  • Stock Information
  • Founded
  • CSBR 1985
  • MAXN 2019
  • Country
  • CSBR United States
  • MAXN Singapore
  • Employees
  • CSBR N/A
  • MAXN N/A
  • Industry
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • MAXN Semiconductors
  • Sector
  • CSBR Health Care
  • MAXN Technology
  • Exchange
  • CSBR Nasdaq
  • MAXN Nasdaq
  • Market Cap
  • CSBR 60.6M
  • MAXN 62.5M
  • IPO Year
  • CSBR 1986
  • MAXN N/A
  • Fundamental
  • Price
  • CSBR $5.23
  • MAXN $0.08
  • Analyst Decision
  • CSBR Strong Buy
  • MAXN Sell
  • Analyst Count
  • CSBR 2
  • MAXN 8
  • Target Price
  • CSBR $6.75
  • MAXN $4.82
  • AVG Volume (30 Days)
  • CSBR 129.1K
  • MAXN 88.0M
  • Earning Date
  • CSBR 09-11-2024
  • MAXN 09-03-2024
  • Dividend Yield
  • CSBR N/A
  • MAXN N/A
  • EPS Growth
  • CSBR N/A
  • MAXN N/A
  • EPS
  • CSBR N/A
  • MAXN N/A
  • Revenue
  • CSBR $51,655,000.00
  • MAXN $828,080,000.00
  • Revenue This Year
  • CSBR $9.14
  • MAXN N/A
  • Revenue Next Year
  • CSBR $10.03
  • MAXN $27.75
  • P/E Ratio
  • CSBR N/A
  • MAXN N/A
  • Revenue Growth
  • CSBR N/A
  • MAXN N/A
  • 52 Week Low
  • CSBR $3.60
  • MAXN $0.08
  • 52 Week High
  • CSBR $7.13
  • MAXN $14.20
  • Technical
  • Relative Strength Index (RSI)
  • CSBR 67.10
  • MAXN 32.24
  • Support Level
  • CSBR $3.60
  • MAXN $0.08
  • Resistance Level
  • CSBR $5.23
  • MAXN $0.10
  • Average True Range (ATR)
  • CSBR 0.35
  • MAXN 0.02
  • MACD
  • CSBR 0.10
  • MAXN 0.01
  • Stochastic Oscillator
  • CSBR 87.57
  • MAXN 10.32

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. They derive revenue primarily from research services.

About MAXN Maxeon Solar Technologies Ltd.

Maxeon Solar Technologies Ltd is engaged in the manufacturing and marketing of premium solar technology. It owns and operates solar cell and panel manufacturing facilities located in Malaysia, Mexico, and the Philippines. The company's primary products are the Maxeon line of interdigitated back contact (IBC) solar cells and panels, and the Performance line (formerly, P-Series) of shingled solar cells and panels. the Maxeon line of solar panels are the highest-efficiency solar panels on the market with an aesthetically pleasing design, and the Performance line of solar panels offers a high-value and cost-effective solution. It is targeted at residential and small-scale commercial customers across the globe. The company derives its revenue from the United States, France, Italy, and others.

Share on Social Networks: